Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Vivekanand Jha(The George Institute for Global Health), Warangkana Pichaiwong, David Peiris(Hebei Medical University), Somchai Eiam‐Ong(Thai Red Cross Society), Rolando Claure‐Del Granado(Universidad Mayor de San Simón), Boris Bogov, Kamol Kitositrangsikun, Vuddhidej Ophascharoensuk, Laura Solá(Institute of Chemistry of Molecular Recognition), Valentine Imonje, Worawon Chailimpamontri, Vijay Kher(Kidney Research UK), Roberto Pecoits‐Filho(Pontifícia Universidade Católica do Paraná), Pichet Lorvinitnun, Goce Spasovski(Ss. Cyril and Methodius University in Skopje), Sirin Jiwakanon, Ikechi G. Okpechi(University of Cape Town), Ghazali Ahmad, Umesh Khanna(Kidney Associates), Anantharaman Vathsala(National University of Singapore), Angela Yee‐Moon Wang(Texas State University), Gregorio T. Obrador(Universidad Panamericana), Charlotte Osafo(University of Ghana), Ratana Chawanasuntorapoj, F. Jarraya(University of Sfax), David C. Wheeler(University College London), Hai An Ha Phan, Sakarn Bunnag, D. Onsuwan, Mustafa Arıcı, Chatri Banchuin, Irma Tchokhonelidze(Tbilisi State Medical University), Fatiu A. Arogundade(Obafemi Awolowo University), Surasak Kantachuvesiri, Brenda R. Hemmelgarn(University of Alberta), Bertram L. Kasiske(University of Minnesota), Tazeen H. Jafar(Apple (Israel)), Rafael Gómez, Guillermo García-García, Lynn Gomez, Gloria Ashuntantang(Université de Yaoundé I), Nazaire Mangani Nseka, Allan J. Collins(University of Richmond), Charles R. Swanepoel(University of Cape Town), Lawrence Y. Agodoa, Sudarshan Ballal(Washington University in St. Louis), Atiporn Ingsathit, Dimitrios Goumenos(General University Hospital of Patras), Ebun L. Bamgboye
Cited by 108
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k